日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical nuclear medicine applications of zirconium-89 immuno-PET: a comprehensive review from a radiopharmaceutical perspective

锆-89免疫PET在临床核医学中的应用：放射性药物视角下的全面综述

期刊:EJNMMI Radiopharmacy and Chemistry
影响因子:3.3
doi:10.1186/s41181-025-00418-8
Dubois, Julien; Deshayes, Emmanuel; Kucharczak, Florentin; Cadet, Marine M; Zhou, Jifang; Paunet, Tom; Fersing, Cyril
免疫/内分泌
发表日期：2026
文献求助 收藏

Process-Related Incidents in Nuclear Medicine: A Four-Year Single-Center Retrospective Analysis to Support the Implementation of a Scenario-Based Radiopharmacy Training

核医学流程相关事件：一项为期四年的单中心回顾性分析，旨在支持基于情景的放射药学培训的实施

期刊:
影响因子:
doi:10.3390/pharmacy14010032
Soualy, Yasmine; Renaud, Stéphane C; Torchio, Jade; Fouillet, Juliette; Ensenat, Julie; Rubira, Léa; Fersing, Cyril
发表日期：2026
文献求助 收藏

Tailored Reaction Conditions and Automated Radiolabeling of [(177)Lu]Lu-PSMA-ALB-56 in a (68)Ga Setting: The Critical Impact of Antioxidant Concentrations

在 (68)Ga 环境下定制反应条件和 [(177)Lu]Lu-PSMA-ALB-56 的自动放射性标记：抗氧化剂浓度的关键影响

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26199642
Vanney, Johanne; Rubira, Léa; Torchio, Jade; Fersing, Cyril
发表日期：2025
文献求助 收藏

Specific reaction conditions for efficient automated (68)Ga-radiolabeling of the FAP-2286 pseudopeptide on a GAIA(®) synthesizer

在 GAIA® 合成仪上高效自动化地对 FAP-2286 假肽进行 (68)Ga 放射性标记的特定反应条件

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1628158
Ammour, Maissa; Torchio, Jade; Renaud, Stéphane C; Rubira, Léa; Fersing, Cyril
FAP
发表日期：2025
文献求助 收藏

Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [(18)F]FDG PET/CT, 20 Years After Primary Diagnosis: A Case Report

一例乳腺小叶癌胃转移病例报告，该病例于原发诊断20年后通过[(18)F]FDG PET/CT检查发现。

期刊:Clinical Case Reports
影响因子:0.6
doi:10.1002/ccr3.70881
Ilonca, Alina Diana; Gudin-de-Vallerin, Amélie; Guillemard, Sophie; Eberle, Marie-Claude; Briant, Jeanne; Guiu, Séverine; Deshayes, Emmanuel; Fersing, Cyril
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents

通过成纤维细胞活化蛋白靶向揭示肿瘤微环境在诊断核医学中的应用：生物学原理和关键显像剂的教学综述

期刊:Biology-Basel
影响因子:3.5
doi:10.3390/biology13120967
Fouillet, Juliette; Torchio, Jade; Rubira, Léa; Fersing, Cyril
成纤维细胞
肿瘤
肿瘤免疫
细胞生物学
肿瘤微环境
发表日期：2024
文献求助 收藏

Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report

临床药学举措助力达拉非尼/曲美替尼联合疗法在碘难治性甲状腺癌中取得卓越疗效：病例报告

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina60071037
Donzé, Charlotte; Leenhardt, Fanny; Vinches, Marie; Eberlé, Marie-Claude; Fersing, Cyril
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

(177)Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods

(177)使用输液泵或蠕动泵给药Lu-Dotatate：两种方法的比较

期刊:European Journal of Hospital Pharmacy-Science and Practice
影响因子:1.5
doi:10.1136/ejhpharm-2022-003489
Donzé, Charlotte; Rubira, Léa; Santoro, Lore; Viarasakd, Malissone; Kotzki, Pierre Olivier; Deshayes, Emmanuel; Fersing, Cyril
发表日期：2024
文献求助 收藏

"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant (68)Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617

“一种标记所有化合物的方法”：一种符合GMP规范的PSMA-11 (68)Ga放射性标记的全自动单一方案，可推广至PSMA-I&T和PSMA-617。

期刊:Current Radiopharmaceuticals
影响因子:1.2
doi:10.2174/0118744710293461240219111852
Fouillet, Juliette; Donzé, Charlotte; Deshayes, Emmanuel; Santoro, Lore; Rubira, Léa; Fersing, Cyril
发表日期：2024
文献求助 收藏

Towards Optimal Automated (68)Ga-Radiolabeling Conditions of the DOTA-Bisphosphonate BPAMD Without Pre-Purification of the Generator Eluate

无需预纯化发生器洗脱液，即可实现DOTA-双膦酸盐BPAMD的最佳自动化(68)Ga放射性标记条件

期刊:Journal of Labelled Compounds & Radiopharmaceuticals
影响因子:0.9
doi:10.1002/jlcr.4128
Souche, Céleste; Fouillet, Juliette; Rubira, Léa; Donzé, Charlotte; Sallé, Audrey; Dromard, Yann; Deshayes, Emmanuel; Fersing, Cyril
AMD
发表日期：2024
文献求助 收藏